Rybelsus® is a brand name for the medication Semaglutide and is classified as a glucagon-like peptide 1 (GLP-1). It is the first oral medication of its kind to be approved by the FDA and is used to treat Class 2 diabetes – a condition where the patient’s body produces insufficient insulin or doesn’t use produced insulin efficiently.